BCL2 and neoplasm: miR-204-5p acts as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC) (Gao et al., 2017; Fan et al., 2023), targets anti-apoptotic protein BCL2 in prostate cancer (PCa) (Lin et al., 2017) and serves as an early diagnostic biomarker in endometrial cancer (EC) (Wu et al., 2022).